<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00847418</url>
  </required_header>
  <id_info>
    <org_study_id>EKBB 351/08, 2009DR1015</org_study_id>
    <nct_id>NCT00847418</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine</brief_title>
  <official_title>Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <brief_summary>
    <textblock>
      The purpose of this study is the determination of blood concentration and the effectiveness
      of esketamine after nasal application.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_arms>1</number_of_arms>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Esketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>esketamine hydrochloride</intervention_name>
    <arm_group_label>Esketamine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male

          -  age ≥18 years ≤ 45 years

          -  healthy

          -  non-smoking

          -  BMI 18-27

        Exclusion Criteria:

          -  abuse of drugs

          -  known or supposed hypersensitivity and/or contraindication against ketamine or
             additives

          -  participation of another clinical study within the last 30 days

          -  chronic obstructed nose breathing or nasal polyps

          -  dug allergy

          -  blood donation within the last two months
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manuel Haschke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Pharmacology and Toxicology, University Hospital Basel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Research Center, University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <state>BS</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2009</study_first_submitted>
  <study_first_submitted_qc>February 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2009</study_first_posted>
  <last_update_submitted>December 1, 2010</last_update_submitted>
  <last_update_submitted_qc>December 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Qualified Person, Stefanie Deuster, PhD.</name_title>
    <organization>Hospital Pharmacy, University Hospital Basel, Switzerland.</organization>
  </responsible_party>
  <keyword>pharmacokinetics</keyword>
  <keyword>ketamine</keyword>
  <keyword>Anesthetics, Dissociative</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

